GE Healthcare Japan

Hino City, Tokyo, Japan (4-7-127, Asahigaoka, Hino-shi, Tokyo, JP 191-0065)  All Japan companies → — Founded 1982
Healthcare Conglomerate Imaging AI Specialist Medical Device / Hardware
Nuclear Medicine Oncology Pulmonology Radiology
Radiology & Imaging AI
Public (as a subsidiary of GE HealthCare Technologies Inc.) — N/A (as a subsidiary of a public company)

Products

True Enhance DL
GE Healthcare Japan Corporation
Radiology & Imaging AI
True Enhance DL is an FDA-cleared deep learning-based AI solution by GE Healthcare Japan Corporation that enhances contrast and clarity in single-energy CT images, estimating monochromatic 50keV images to support confident diagnoses in radiology.
Revolution Ascend
GE Healthcare Japan Corporation
Radiology & Imaging AI
Revolution Ascend is a GE Healthcare CT X-ray system featuring AI-driven workflow (Effortless Workflow) and deep learning image reconstruction (TrueFidelity DL, True Enhance DL) to optimize efficiency, image quality, and patient experience in diagnostic imaging.
Deep Learning Image Reconstruction
GE Healthcare Japan Corporation
Radiology & Imaging AI
GE Healthcare's Deep Learning Image Reconstruction (DLIR) is an AI-powered technology that enhances medical image quality by reducing noise and artifacts across CT, MRI, SPECT, and Mammography, improving diagnostic confidence and operational efficiency.

See all 3 products →

About GE Healthcare Japan

GE Healthcare Japan Corporation is a prominent healthcare technology company operating in Japan, a subsidiary of the global GE HealthCare. The company develops, manufactures, markets, and services a comprehensive range of medical diagnostic imaging equipment, including CT, MRI, ultrasonic diagnostic equipment, X-Ray equipment, and cell analysis devices. Beyond hardware, GE Healthcare Japan is also involved in biotechnology-related businesses and specializes in the production of radiopharmaceuticals and medical devices such as ultrasound probes.

Established in 1982 as Yokogawa Medical System, a joint venture with Yokogawa Electric Corporation, the company was rebranded as GE Healthcare Japan Corporation in 2009. It plays a crucial role in addressing Japan’s healthcare challenges, particularly those stemming from an aging population, by collaborating with local research institutes, university hospitals, and other Japanese companies to create innovative solutions.

A key focus for GE Healthcare Japan is the integration of artificial intelligence (AI), cloud, and digital technologies to revolutionize healthcare. This includes enhancing medical devices, streamlining clinical workflows, and improving overall hospital efficiency. The company aims to deliver smarter, connected, and scalable solutions, such as AI-enabled portable ultrasound technology, to provide more personalized, precise, and accessible patient care, even in underserved regions.

Focus Areas

Medical diagnostic imaging ultrasound CT MRI X-ray biotechnology radiopharmaceuticals AI solutions digital health precision care workflow optimization patient care solutions molecular imaging advanced visualization healthcare IT

Business Intelligence

Key InvestorsN/A (as a subsidiary of a public company)
PartnershipsNational Cerebral and Cardiovascular Center (NCVC), Murata Manufacturing, Okabe Marking Systems, Taiyo Pharma Tech, Amazon Web Services (AWS)
AcquisitionsNihon Medi-Physics (NMP) (full acquisition completed March 2025)
TechnologyCloud-native (CareIntellect), edge computing, AI operating system, Predix (IoT platform), deep learning algorithms, AI-enabled devices
FDA Clearances100+ (for GE HealthCare AI-enabled medical devices as of July 2025) cleared products (estimated)

What Physicians Need to Know

Medical Diagnostic Imaging
GE Healthcare Japan offers a comprehensive suite of advanced diagnostic imaging solutions including CT, MRI, ultrasound, X-ray, and molecular imaging systems. Their innovations focus on delivering high-quality images, faster exam workflows, and improved clinical outcomes. Key offerings include advanced MRI systems with AIRu2122 technology for patient comfort and performance, next-generation spectral photon counting CT (Photonovau2122 Spectra (i)) for ultra-high-definition imaging, and digital X-ray systems (Definiumu2122 Pace Select ET) leveraging AI for accurate positioning and streamlined workflows. They also provide handheld ultrasound devices (Vscan Air SL with Caption AIu2122) for rapid, AI-guided cardiac assessments at the point of care.
Biotechnology & Radiopharmaceuticals
GE HealthCare Japan has significantly strengthened its position in radiopharmaceuticals through the full acquisition of Nihon Medi-Physics (NMP), a leading company in Japan specializing in diagnostic radiopharmaceuticals and molecular imaging agents. NMP's portfolio includes crucial radiotracers like VIZAMYLu00ae, DaTSCANu00ae, and MYOVIEWu00ae used in neurology, cardiology, and oncology. This integration enhances their ability to provide end-to-end solutions for Theranostics, covering drug discovery, disease diagnosis, and treatment monitoring, aiming to improve patient access to next-generation radiopharmaceuticals.
AI Solutions & Digital Health
GE HealthCare Japan is at the forefront of AI integration in healthcare, consistently topping the FDA's list for AI-enabled medical device authorizations. Their digital strategy, centered on 'precision care,' leverages AI and cloud computing to build smarter devices, guide data-driven care, and enhance hospital efficiency. Solutions like Command Center optimize patient flow and resource management, while CareIntellect uses AI to enable personalized care. They are actively embedding AI into every device to transform clinical workflows and reduce cognitive burden on clinicians.
Precision Care & Workflow Optimization
The company's precision care strategy aims to make healthcare more efficient, clinicians more effective, and therapies more precise. They offer AI-powered solutions that streamline workflows, automate repetitive tasks (e.g., in CT imaging), and reduce administrative burdens. This includes advanced visualization platforms that integrate imaging analytics and AI-powered workflows (e.g., MIM Software solutions) to aid in diagnosis and treatment planning across various disease states, ultimately improving operational efficiencies and patient outcomes.
Key Differentiators
GE HealthCare Japan stands out due to its comprehensive, end-to-end solutions spanning pharmaceutical diagnostics, imaging equipment, and digital/AI platforms. Their leadership in AI innovation, evidenced by numerous FDA authorizations, and a strategic focus on 'precision care' differentiate them. Furthermore, their commitment to local innovation and collaboration within Japan, coupled with a culture of 'Kaizen' (continuous improvement) in manufacturing, allows them to develop products and services closely tailored to patient needs in the region.
Technology Stack (Core Technologies)
GE HealthCare Japan's core technology stack is heavily reliant on AI and deep learning for image reconstruction (e.g., AIR Recon DL, deep learning-based CT), workflow automation, and diagnostic assistance. They leverage cloud computing for data-driven insights and flexible solutions. Key proprietary platforms include the Edison intelligence platform (globally), Command Center, CareIntellect, and Advantage Workstation (AW) for advanced visualization. They also utilize IoT platforms like 'Predix' for operational efficiency and advanced detector technologies such as Deep Silicon for cutting-edge imaging.
Physician Tip

For physicians, GE Healthcare Japan's offerings translate into improved diagnostic accuracy and speed through AI-powered imaging and advanced visualization, enabling faster and more precise diagnoses. The integration of AI into workflows significantly enhances efficiency, reduces administrative burdens, and helps mitigate clinician burnout. Their focus on precision medicine, particularly with molecular imaging and radiopharmaceuticals, supports personalized treatment plans for better patient outcomes. Additionally, portable, AI-enabled devices expand access to quality care, even in remote settings, empowering healthcare professionals across all skill levels. The cohesive integration of patient data across modalities fosters better inter-departmental collaboration.

GE HealthCare Japan emphasizes seamless integration of its AI and digital solutions with existing hospital systems and across various imaging modalities. Their platforms, such as Command Center and CareIntellect, are designed to consolidate diverse hospital data for a centralized, longitudinal view of the patient. The acquisition of MIM Software further enhances their ability to integrate advanced imaging analytics and AI-powered workflows into their visualization offerings, supporting a comprehensive approach to precision care. They are committed to ensuring AI's impact relies on seamless integration with local systems and fostering community-driven collaborations.

Products by GE Healthcare Japan

3 products in the directory

True Enhance DL
GE Healthcare Japan Corporation
Radiology & Imaging AI
True Enhance DL is an FDA-cleared deep learning-based AI solution by GE Healthcare Japan Corporation that enhances contrast and clarity in single-energy CT images, estimating monochromatic 50keV images to support confident diagnoses in radiology.
Revolution Ascend
GE Healthcare Japan Corporation
Radiology & Imaging AI
Revolution Ascend is a GE Healthcare CT X-ray system featuring AI-driven workflow (Effortless Workflow) and deep learning image reconstruction (TrueFidelity DL, True Enhance DL) to optimize efficiency, image quality, and patient experience in diagnostic imaging.
Deep Learning Image Reconstruction
GE Healthcare Japan Corporation
Radiology & Imaging AI
GE Healthcare's Deep Learning Image Reconstruction (DLIR) is an AI-powered technology that enhances medical image quality by reducing noise and artifacts across CT, MRI, SPECT, and Mammography, improving diagnostic confidence and operational efficiency.

What the Web Says

GE Healthcare Japan is a global leader in medical technology, offering a wide range of products including imaging, ultrasound, and healthcare IT solutions. The company is dedicated to advancing healthcare through innovation and digital solutions, with a focus on improving operational efficiencies and patient care. While product reviews are generally positive, highlighting ease of use and advanced features, employer reviews present a mixed picture regarding work-life balance, management, and company culture.

Overall: Mixed

Strengths

  • Advanced medical technology and digital solutions.
  • Products like Virence Centricity are praised for their easy interface and readability.
  • GE Encompass is a cost-effective solution for managing hospital assets.
  • Strong focus on integrating intelligence into technologies for earlier diagnosis and personalized treatments.
  • Opportunities for global collaboration and professional development for employees.
  • Some employees report a great team environment and supportive coworkers.

Limitations

  • Some products, like GE Encompass, could benefit from more AI-powered features.
  • Management can be unsupportive and the training system could be improved.
  • Unstructured onboarding process.
  • Concerns about micromanagement and lack of psychological safety in the workplace.
  • High turnover due to low staffing and long working hours.
  • Criticism regarding unfair practices, such as punishing organizations for not buying contracts and high hourly rates for support.

Based on reviews from: G2, Glassdoor, Indeed, Comparably, Reddit, Which Medical Device, Capterra, GE HealthCare

Last updated: 2026-07-18

Videos

News, demos, and interviews about GE Healthcare Japan.

Loading videos...

Videos load interactively. If none appear, search YouTube for GE Healthcare Japan →

View all on YouTube

Press & Coverage

Business Wire
GE HealthCare Completes Acquisition of Nihon Medi-Physics (NMP), a Leading Radiopharmaceutical Company in Japan
GE HealthCare completed its acquisition of Sumitomo Chemical's 50% stake in Nihon Medi-Physics (NMP), gaining full ownership and aiming to enhance patient access to next-generation radiopharmaceuticals in Japan. Kevin O'Neill, President & CEO of GE HealthCare's Pharmaceutical Diagnostics segment, will also become President of NMP.
2025-03
BioSpace
GE HealthCare to Acquire Remaining 50% Stake in Nihon Medi-Physics (NMP), a Leading Radiopharmaceutical Company in Japan, from Sumitomo Chemical
GE HealthCare announced its agreement to acquire the remaining 50% stake in Nihon Medi-Physics (NMP) from Sumitomo Chemical, aiming to strengthen its precision care strategy and expand its presence in Japan's molecular imaging market. The acquisition was expected to close in early 2025, subject to regulatory approvals.
2024-12
GE Healthcare
GE Healthcare Pharma and Taiyo Pharma Tech Signs a Contract Manufacturing Agreement to Manufacture Contrast Media*
GE Healthcare Pharma and Taiyo Pharma Tech Co., Ltd. signed a contract manufacturing agreement for diagnostic imaging contrast media, effective March 3, 2022. This agreement secures a reliable domestic manufacturing site for GE Healthcare Pharma in Japan and ensures a stable supply of contrast agents.
2022-02
Nikkei Research Inc.
How will DX grow in the Healthcare Industry?
GE Japan is involved in a project at Kurashiki Central Hospital, migrating medical equipment to an IoT system to analyze staff paths and equipment operation rates, which has led to identifying underutilized equipment and increasing revenue through improved medical fee claims. The article discusses the slow adoption of medical DX in Japan but highlights potential in medical institutions.
2021-12
Daiichi Sankyo
Daiichi Sankyo to transfer marketing authorization rights for four diagnostic imaging agents in Japan to GE Healthcare
Daiichi Sankyo agreed to transfer the exclusive development and marketing rights in Japan for four diagnostic imaging agents to GE Healthcare Pharma, with the transfer of marketing authorization rights expected to be complete in March 2020. This move aims to strengthen GE Healthcare's position as a leading innovator in medtech and diagnostics in Japan.
2019-06
FDA
GE Healthcare Japan Corporation - Establishment Registration & Device Listing - FDA
GE Healthcare Japan Corporation has an active establishment registration with the FDA under registration number 9612283, with its business trade name listed as GE Healthcare in Hino-Shi, Tokyo. The registration status was last updated in 2026.
2026-05
GE HealthCare
Taking a leap: How tools and tech are advancing access to quality healthcare around the world
This article highlights how technological advancements, such as handheld ultrasound scanners, are improving healthcare access globally, including in Japan where Dr. Keigo Yasukawa uses a portable ultrasound for house calls in remote islands. GE HealthCare is contributing to these efforts by developing patient care technology.
2026-05
GE HealthCare
GE HealthCare Research - Explore the latest in Science and AI Research in Healthcare
GE HealthCare is actively involved in AI innovation to redefine healthcare diagnosis, treatment, and patient care, with recent articles focusing on digital twins for hospital operations and frameworks for responsible AI in healthcare. They also offer over 20 hours of AI education publicly through HelloAI.
2026-07

Frequently Asked Questions

GE HealthCare is investing in AI-enabled devices across imaging modalities, including new vascular offerings, next-generation MR, and photon-counting CT systems planned for late 2025 and into 2026, alongside a new advanced digital X-ray system launched in July 2025. Their imaging solutions, such as Edison True PACS, are designed to seamlessly integrate AI algorithms into workflows without additional clicks, supporting enterprise visualization and archiving within a single platform.
GE HealthCare leverages AI to build smarter devices, guide data-driven care, and enhance hospital efficiency with solutions like Effortless Workflow for CT and Critical Care Suite for X-ray, significantly improving diagnostic accuracy and reducing interpretation times. Their AI and digital solutions are central to their D3 strategy, aiming to embed AI in every device and tailor digital solutions to each patient's care journey, thereby reducing cognitive burden and optimizing hospital operations for precision care.
GE HealthCare's Pharmaceutical Diagnostics (PDx) segment develops and manufactures pharmaceutical imaging agents used globally for over 130 million procedures annually. They are acquiring full ownership of Nihon Medi-Physics (NMP) in Japan to enhance patient access to next-generation radiopharmaceuticals for detecting and diagnosing diseases across neurology, cardiology, and oncology, supporting precision medicine through earlier diagnosis and tailored treatment plans.
GE HealthCare embeds cybersecurity practices across all business operations, from product development to maintenance, following a Secure Development Lifecycle approach to manage risks effectively. They offer solutions like Skeye cybersecurity for 24/7 risk management of networked medical devices, adhere to stringent standards, and collaborate with global regulators to ensure data privacy and compliance.
GE HealthCare provides comprehensive technical support, maintenance services, and software updates as part of long-term contracts to ensure optimal performance and longevity of its medical equipment. They offer various education and technical training programs, including clinical application training for workflow optimization, product service training for equipment operation and maintenance, and digital education, available through virtual courses and their GE HealthCare Institute.
GE HealthCare's solutions are designed to enhance patient experience by focusing on comfort, reducing anxiety, minimizing waiting times, and providing faster results, alongside offering consulting and training to foster patient-centric care. Their AI-driven software, such as Command Center, helps hospitals manage patient flow, streamline operations, and make data-driven decisions in real-time, leading to improved efficiency and staff satisfaction.
GE HealthCare's long-term vision centers on continuous innovation, particularly in AI and digital solutions, backed by significant annual R&D investments exceeding $1 billion, aiming to embed AI in every device and develop advanced imaging technologies. Since its spin-off in January 2023, the company has demonstrated strong market leadership and stability, pursuing strategic acquisitions and partnerships to ensure sustainable growth and a robust product pipeline.

Related Companies

Google DeepMind is a leading artificial intelligence (AI) research laboratory, a subsidiary of Alphabet Inc., dedicated to developing advanced AI systems to benefit humanity. The company focuses on creating general-purpose AI that can learn and solve complex problems, drawing inspiration from neuroscience and machine learning. Their work spans various fields, including healthcare, scientific discovery, and […]

TalkToMedi is a Canadian healthcare AI company that has developed a clinical-grade voice AI platform called MEDI. This platform is designed to automate patient communication and administrative tasks for medical clinics, including family medicine, specialty clinics, allied health, and physiotherapy. MEDI handles high-volume patient calls, automating appointment inquiries, booking, rescheduling, and cancellations based on the […]

Menaela is an AI-first practice management system designed for solo practitioners, small private clinics, and clinic owners. It integrates patient communication, scheduling, CRM, and medical documentation into a single platform, aiming to replace multiple disconnected tools and bots. The system features an AI practice manager that understands natural-language requests, utilizes real clinic data, and performs […]

Avie is operated by AVIE TECNOLOGIA LTDA, headquartered in Santo André, São Paulo, Brazil. Avie provides WhatsApp reception in Brazilian Portuguese, appointment scheduling, rescheduling and cancellations through Google Calendar or Feegow, clinic CRM, follow-up messages and an online booking website. Clinic staff can review conversations and take over when human support is needed. Clinic CRM […]

Saile is a physician-founded healthcare technology company that addresses critical inefficiencies in healthcare staffing and credentialing. Their AI-powered platform acts as a “universal credential passport” for physicians, centralizing and managing all medical licenses, certifications, and CME credits in one secure, portable vault. This system aims to significantly reduce the administrative burden and delays associated with […]

Data Capture Experts (DCE) is an Australian-based healthcare AI company that is at the forefront of digital health transformation. They specialize in developing and implementing digital health platforms that integrate data, technology, and human-centered design to create intuitive and connected healthcare systems. Their flagship platform, DC2Vue, is designed to go beyond traditional Electronic Medical Records […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.